top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:624-632, doi:10.1016/j.jcin.2009.05.004
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Nikolsky, E.
Right arrow Articles by Stone, G. W.
PubMed
Right arrow Articles by Nikolsky, E.
Right arrow Articles by Stone, G. W.
Related Collections
Right arrowRelated Article

Clinical Research

Prognostic Impact of Blood Transfusion After Primary Angioplasty for Acute Myocardial Infarction

Analysis From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial

Eugenia Nikolsky, MD, PhD*, Roxana Mehran, MD*, H. Mehrdad Sadeghi, MD{dagger}, Cindy L. Grines, MD{ddagger}, David A. Cox, MD§, Eulogio Garcia, MD||, James E. Tcheng, MD, John J. Griffin, MD#, Giulio Guagliumi, MD**, Thomas Stuckey, MD{dagger}{dagger}, Mark Turco, MD{ddagger}{ddagger}, Martin Fahy, MSc*, Alexandra J. Lansky, MD*, Gregg W. Stone, MD*,*

* Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
{dagger} Sharp Chula Vista Medical Center, Chula Vista, California
{ddagger} William Beaumont Hospital, Royal Oak, Michigan
§ Mid Carolina Cardiology, Charlotte, North Carolina
|| Hospital Gregorio Maranon, Madrid, Spain
Duke Clinical Research Institute, Durham, North Carolina
# Virginia Beach General Hospital, Virginia Beach, Virginia
** Ospedali Riuniti di Bergamo, Bergamo, Italy
{dagger}{dagger} Moses Cone Memorial Hospital, Greensboro, North Carolina
{ddagger}{ddagger} Washington Adventist Hospital, Tacoma Park, Maryland

* Reprint requests and correspondence: Dr. Gregg W. Stone, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, New York 10032 (Email: gs2184{at}columbia.edu).

Objectives: We sought to determine the relationship between red blood cell (RBC) transfusion and clinical outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI).

Background: The implications of RBC transfusion in patients undergoing primary PCI for AMI have not been evaluated.

Methods: Clinical outcomes of patients from the prospective, randomized CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial were analyzed by administration of in-hospital RBC transfusion not related to coronary artery bypass surgery.

Results: Of 2,060 randomized patients, 82 (3.98%) received RBC transfusion during the index hospitalization, including 33 (1.60%) with moderate/severe bleeding and 49 (2.38%) without overt major bleeding. Transfusion was independently associated with baseline anemia (odds ratio [95% confidence interval]: 4.44 [2.60 to 7.58], p < 0.0001), older age (1.03 [1.01 to 1.06], p = 0.002), triple-vessel disease (2.54 [1.47 to 4.38], p = 0.0008), and female sex (1.04 [1.02 to 1.06], p = 0.0008). Patients transfused versus not transfused had significantly higher rates of 1-year mortality (23.9% vs. 3.4%), disabling stroke (2.5% vs. 0.5%), reinfarction (7.0% vs. 2.2%), and composite major adverse cardiac events (41.0% vs. 16.6%) (all p values < 0.01). After multivariable adjustment for potential confounders including transfusion propensity, RBC transfusion was independently associated with mortality at 30 days (hazards ratio: 4.71, p = 0.0005) and 1 year (hazards ratio: 3.16, p = 0.0005).

Conclusions: An RBC transfusion after primary PCI in AMI may be harmful, which is consistent with the findings from other studies after PCI in the noninfarct setting. Alternatively, RBC transfusion may be a marker of markedly increased risk. Randomized studies are warranted to determine the optimal threshold for RBC transfusion in patients with AMI undergoing mechanical reperfusion therapy.

Key Words: transfusion • primary angioplasty • myocardial infarction • bleeding

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  CABG = coronary artery bypass graft
  CAD = coronary artery disease
  MI = myocardial infarction
  PCI = percutaneous coronary intervention
  RBC = red blood cell
  STEMI = ST-segment elevation myocardial infarction
  TIMI = Thrombolysis In Myocardial Infarction


Related Article

Blood Transfusion After Myocardial Infarction: Friend, Foe, or Double-Edged Sword?
Fernando Alfonso
J. Am. Coll. Cardiol. Intv. 2009 2: 633-635. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
T. Mann
Transradial Access: Just Do It!
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1065 - 1066.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
F. Alfonso
Blood Transfusion After Myocardial Infarction: Friend, Foe, or Double-Edged Sword?
J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 633 - 635.
[Full Text] [PDF]



 
   
 
home link current link search link archive link topics link cardiology careers link